Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC10712 Imiquimod hydrochloride

    盐酸咪喹莫特; R 837 hydrochloride

    A TLR7 agonist

  3. GC12013 Sodium salicylate

    水杨酸钠; Salicylic acid sodium salt; 2-Hydroxybenzoic acid sodium salt

    水杨酸钠(水杨酸钠盐)抑制环加氧酶 2(COX-2)活性,与转录因子(NF-κB)激活无关。
  4. GC13030 (R)-(-)-Ibuprofen

    (R)-(-)-布洛芬; (R)-Ibuprofen

    A less potent enantiomer of ibuprofen
  5. GC16889 Nisoldipine

    尼索地平; BAY-k 5552

    A calcium channel inhibitor
  6. GC16590 Dimethyl Fumarate

    富马酸二甲酯

    An antioxidant with immunological actions
  7. GC17961 Suplatast Tosylate

    甲磺司特; IPD 1151T

    An antiallergic agent
  8. GC11719 HG-9-91-01

    N-(2,4-二甲氧基苯基)-N'-(2,6-二甲基苯基)-N-[6-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]脲,SIK inhibitor 1

    An inhibitor of salt-inducible kinases
  9. GC16607 Mesalamine

    5-氨基水杨酸; Mesalamine; 5-ASA; Mesalazine

    An NSAID and active metabolite of sulfasalazine, balsalazide, and olsalazine
  10. GC14435 Zileuton sodium

    齐留通钠盐; A 64077 sodium; Abbott 64077 sodium

    A reversible inhibitor of 5-lipoxygenase
  11. GC14498 AP20187

    B/B Homodimerizer

    A CID for FKBP fusion proteins
  12. GC16233 Tacrolimus (FK506)

    他克莫司; FK506; Fujimycin; FR900506

    他克莫司 (FK506) 是一种具有强效免疫抑制作用的大环内酯类抗生素,从筑波链霉菌中分离出来,以前曾用于预防人类同种异体移植和治疗自身免疫性疾病。
  13. GC13650 Resiquimod (R-848)

    雷西莫特; R848; S28463

    Resiquimod (R848)是一种具有潜在抗病毒活性的咪唑喹啉类化合物。
  14. GC12180 IKK-16 (IKK Inhibitor VII) IKK-16 (IKK Inhibitor VII) 是一种选择性 IκB 激酶 (IKK) 抑制剂,作用于 IKK2、IKK 复合物和 IKK1,IC50 分别为 40 nM、70 nM 和 200 nM。
  15. GC16658 Vinpocetine

    长春西汀; Ethyl apovincaminate

    An inhibitor of PDE1
  16. GC13345 NXY-059

    4-[[(1,1-二甲基乙基)氧化亚氨基]甲基]-1,3-苯二磺酸二钠,NXY-059

    A free radical spin trap
  17. GC14633 HPGDS inhibitor 1

    6-(3-氟苯基)-N-[1-(2,2,2-三氟乙基)-4-哌啶基]-3-吡啶羧酰胺

    An inhibitor H-PGDS
  18. GC11438 JSH-23

    4-甲基-N1-(3-苯基丙基)-1,2-苯二胺

    JSH-23 对核转位和 NF-κB 转录活性具有抑制作用,在脂多糖 (LPS) 刺激的巨噬细胞中 IC50 值为 7.1 μM RAW 264.7 。
  19. GC10692 Caffeic Acid Phenethyl Ester

    咖啡酸苯乙酯

    A potent inhibitor of NF-κB activation
  20. GC12372 SC-514

    GK 01140

    Selective inhibitor of IKK2
  21. GC10345 Bay 11-7085

    (2E)-3-[[4-叔丁基苯基]磺酰基]-2-丙烯腈,BAY 11-7083

    An irreversible inhibitor of IκBα phosphorylation
  22. GC10295 Chloroquine diphosphate

    磷酸氯喹

    An aminoquinoline

  23. GC12628 ITE An endogenous AhR agonist
  24. GC12040 L-Kynurenine

    L-犬尿氨酸

    L-Kynurenine是L-色氨酸的代谢物,也是一种芳香烃受体 (aryl hydrocarbon receptor; AhR) 激动剂。
  25. GC16220 CH 223191

    1-甲基-N-[2-METHYL-4-[2-(2-甲苯基)二氮烯基]苯基-1H-吡唑-5-甲酰胺

    CH 223191是一种有效且特异性的芳烃受体(AhR)拮抗剂,可抑制TCDD介导的AhR核转位和DNA结合,并抑制TCDD诱导的荧光素酶活性,IC50为0.03 μM。
  26. GC11819 Strontium Ranelate

    雷尼酸锶; Distrontium renelate; S12911

    An antiosteoporotic agent
  27. GC17707 Bismuth Subsalicylate

    次水杨酸铋; Bismuth oxysalicylate; Bismuth(III) salicylate basic

    Bismuth Subsalicylate 是一种有效的、具有口服活性的抗酸剂和止泻剂。
  28. GC10474 Laquinimod (ABR-215062)

    拉喹莫德; ABR-215062

    An immunomodulator
  29. GC16880 Flurbiprofen

    氟比洛芬; dl-Flurbiprofen

    A non-selective COX inhibitor
  30. GC15605 Ezetimibe

    依泽替米贝; SCH 58235

    A cholesterol transport inhibitor
  31. GC11786 Acetylcysteine

    乙酰半胱氨酸; N-Acetylcysteine; N-Acetyl-L-cysteine; NAC

    乙酰半胱氨酸是半胱氨酸的 N-乙酰基衍生物。
  32. GC15714 SC 144

    吡嗪羧酸2-(7-氟吡咯并[1,2-A]喹喔啉-4-基)酰肼

    A gp130 inhibitor
  33. GC16014 Zileuton

    齐留通; A 64077; Abbott 64077

    A reversible inhibitor of 5-lipoxygenase
  34. GC16868 Sulfasalazine

    柳氮磺吡啶; NSC 667219

    A prodrug form of 5-aminosalicylic acid
  35. GC14751 Malotilate

    马洛替酯; NKK 105

    A hepatoprotective agent
  36. GC15548 Ellagic acid

    鞣花酸

    Polyphenolic antioxidant
  37. GC16407 Imiquimod

    咪喹莫特; R 837

    A TLR7 agonist

  38. GC17608 Lidocaine

    利多卡因; Lignocaine

    An Analytical Reference Standard
  39. GC17621 TPCA-1

    5-(4-氟苯基)-2-脲基噻吩-3-甲酰胺

    A selective inhibitor of IKK2
  40. GC16280 DMXAA (Vadimezan)

    2,5-己酮可可碱,AS-1404, 5,6-MeXAA, NSC-640488, Vadimezan

    DMXAA (Vadimezan)是一种选择性的DT-心肌黄酶抑制剂,Ki值为20μM,IC50值为62.5μM。
  41. GC17043 StemRegenin 1 (SR1)

    SR1

    Antagonizes hematopoietic stem cell differentiation
  42. GC11573 BX795

    N-[3-[[5-碘-4-[[3-[(2-噻吩基羰基)氨基]丙基]氨基]-2-嘧啶基]氨基]苯基]-1-吡咯烷甲酰胺

    A multi-kinase inhibitor
  43. GC12604 Fumonisin B1

    伏马菌素B1

    A mycotoxin

  44. GC10282 Piperlongumine

    荜茇酰胺; Piplartine

    Piperlongumine是从Piper longum L.中提取的天然生物碱化合物,具有多种药理活性,包括抗肿瘤、脂质代谢调节、抗血小板聚集和镇痛活性等。
  45. GC17255 Gliotoxin

    胶霉毒素,Aspergillin

    An immunosuppressive mycotoxin with diverse biological effects
  46. GC14402 Triptolide

    雷公藤甲素; PG490

    雷公藤甲素(Triptolide)是一种二萜三环氧化物,首次从药用植物雷公藤 (Tripterygium wilfordii) 中分离出来,具有免疫抑制,抗炎,抗增殖和抗肿瘤作用。
  47. GC17996 Toll-like receptor modulator

    2-氨基-8-(全氟乙基)-3H-苯并[B]氮杂卓-4-甲酸乙酯

    Toll 样受体调节剂是调节免疫功能的 TLR7/8 调节剂。
  48. GC11294 TAK-242 S enantiomer

    Resatorvid (S enantiomer);TAK242 (S enantiomer);TAK 242 (S enantiomer)

    TLR 4 signaling inhibitor
  49. GC16148 TAK-242

    瑞沙托维; TAK-242; CLI-095

    TAK 242 是一种 Toll 样受体 4 (TLR4) 信号转导抑制剂。
  50. GC17136 MRT67307

    N-[3-[[5-环丙基-2-[[3-(4-吗啉基甲基)苯基]氨基]-4-嘧啶基]氨基]丙基]环丁烷甲酰胺,MRT 67307;MRT-67307

    A kinase inhibitor
  51. GC14989 MLN120B

    N-(6-氯-7-甲氧基-9H-吡啶并[3,4-B]吲哚-8-基)-2-甲基-3-吡啶甲酰胺,ML120B;MLN 120B;MLN-120B

    An IKKβ inhibitor

Items 4051 to 4100 of 4267 total

per page

Set Descending Direction